IMNM Competitors & Alternatives
Compare Immunome Inc with similar stocks in the same industry
Biotechnology
IMNM
Main Stock$17.73
Tradestie Score
59
Market Cap
$987.09M
Revenue Growth
-1.0%
Analyst Upside
+98.5%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.66
|
$2.23B | - | 52 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.22
|
$2.22B | - | 66 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$50.16
|
$2.21B | - | 66 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.26
|
$2.18B | - | 56 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.22
|
$2.08B | - | 50 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.58
|
$2.02B | - | 46 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.05
|
$2.01B | - | 46 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$30.90
|
$1.97B | - | 59 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.41
|
$1.92B | - | 61 | Compare |
More IMNM Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry